Skip to main content
Loading ResearchHub…
References for External validation of the NADIR model for early prostate‐specific antigen response prediction in enzalutamide‐treated metastatic hormone‐sensitive prostate cancer: An analysis of the ARCHES trial | ResearchHub - ResearchHub